| scholarly article | Q13442814 |
| P50 | author | Matthew L Senjem | Q30505707 |
| Clifford Jack | Q30505709 | ||
| Ronald C. Petersen | Q56839853 | ||
| David S Knopman | Q63967707 | ||
| Zbigniew K Wszolek | Q64754704 | ||
| Bradley F Boeve | Q67501037 | ||
| Stephen Weigand | Q88487393 | ||
| Jennifer L Whitwell | Q99637904 | ||
| Jeffrey L Gunter | Q107209317 | ||
| P2093 | author name string | R Rademakers | |
| K A Josephs | |||
| M C Baker | |||
| M DeJesus-Hernandez | |||
| P2860 | cites work | Classification of primary progressive aphasia and its variants | Q24594803 |
| Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics | Q24630362 | ||
| Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features | Q24630410 | ||
| Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS | Q24633692 | ||
| A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD | Q24634583 | ||
| 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment | Q24648319 | ||
| Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain | Q25855787 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 | Q28253639 | ||
| Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 | Q28253651 | ||
| Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 | Q28274687 | ||
| Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 | ||
| Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration | Q33581412 | ||
| Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration | Q33999208 | ||
| Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations | Q34134801 | ||
| Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain | Q34656983 | ||
| Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN. | Q35119603 | ||
| Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features | Q36198642 | ||
| Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease | Q36445053 | ||
| Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies | Q37036238 | ||
| Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN | Q37180625 | ||
| Methodological considerations for measuring rates of brain atrophy | Q37339974 | ||
| Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations | Q37368352 | ||
| Correction of differential intensity inhomogeneity in longitudinal MR images | Q44987375 | ||
| The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. | Q48594940 | ||
| Mixed-Effects Models in Sand S-PLUS | Q58040120 | ||
| P433 | issue | 5 | |
| P921 | main subject | frontotemporal dementia | Q18592 |
| dementia | Q83030 | ||
| P304 | page(s) | 745-752 | |
| P577 | publication date | 2015-02-12 | |
| P1433 | published in | European Journal of Neurology | Q15757256 |
| P1476 | title | Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images | |
| P478 | volume | 22 |
| Q40118660 | Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration |
| Q46243821 | Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia |
| Q60046457 | Biomarkers for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Associated With Hexanucleotide Expansion Mutations in |
| Q47109814 | C9ORF72 and the FTD-ALS spectrum: A systematic review of neuroimaging studies |
| Q48074105 | Comprehensive Clinical Evaluations of Frontotemporal Dementia Contrasting to Alzheimer's Disease (oFTD Study). |
| Q91642348 | Deformation based morphometry study of longitudinal MRI changes in behavioral variant frontotemporal dementia |
| Q47990209 | Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes |
| Q52646410 | Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. |
| Q92239604 | Divergent patterns of TDP-43 and tau pathologies in primary progressive aphasia |
| Q47380744 | Early Cognitive, Structural, and Microstructural Changes in Presymptomatic C9orf72 Carriers Younger Than 40 Years. |
| Q90203081 | Evidence of corticofugal tau spreading in patients with frontotemporal dementia |
| Q93083717 | FTD spectrum: Neuroimaging across the FTD spectrum |
| Q90182692 | Genetic predictors of survival in behavioral variant frontotemporal degeneration |
| Q90410936 | Imaging Biomarkers for Neurodegeneration in Presymptomatic Familial Frontotemporal Lobar Degeneration |
| Q38670219 | Imaging and fluid biomarkers in frontotemporal dementia. |
| Q37044191 | Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease? |
| Q37497445 | Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype |
| Q60923357 | Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia |
| Q55484201 | Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers. |
| Q57039891 | Morphometric MRI as a diagnostic biomarker of frontotemporal dementia: A systematic review to determine clinical applicability |
| Q64228084 | Neurocognitive mechanisms of theory of mind impairment in neurodegeneration: a transdiagnostic approach |
| Q37208495 | Neurofilament light chain: a biomarker for genetic frontotemporal dementia |
| Q51800676 | Neuroimaging in Dementia. |
| Q26782984 | Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia |
| Q47623958 | Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease |
| Q53441607 | Progress and Challenges in Frontotemporal Dementia Research: A 20-Year Review. |
| Q42655942 | Prosocial deficits in behavioral variant frontotemporal dementia relate to reward network atrophy |
| Q92463670 | Rates of lobar atrophy in asymptomatic MAPT mutation carriers |
| Q90029747 | Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders |
| Q48728734 | Reply: C9orf72 mutations and the puzzle of cerebro-cerebellar network degeneration |
| Q92085505 | Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI |
| Q30996675 | Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models. |
| Q92856453 | The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications |
| Q92496794 | Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS |
| Q90440666 | Ventricular volume expansion in presymptomatic genetic frontotemporal dementia |
| Q52095958 | von Economo Neuron Density and Thalamus Volumes in Behavioral Deficits in Frontotemporal Dementia Cases with and without a C9ORF72 Repeat Expansion. |
Search more.